site stats

Laurikka-routti

WebMarjut Laurikka-Routti, Maija Haukkamaa, Pekka Lähteenmäki. Department of Obstetrics and Gynecology; Research output: Contribution to journal › Article › Scientific › peer-review. Overview; Original language: English: Journal: Fertility and Sterility : official journal of the American Fertility Society : Volume: 58: Pages (from-to) WebM Laurikka-Routti 1 , M Haukkamaa, O Heikinheimo. Affiliation 1 Department of Medical Chemistry, University of Helsinki, Finland. PMID: 2387151 DOI: 10.1016/0010 …

Pharmacokinetics and bioavailability of ST 1435 administered by ...

WebLaurikka-Routti, M., & Haukkamaa, M. (1992). A contraceptive subdermal implant releasing the progestin ST-1435 - ovarian-function, bleeding patterns, and side-effects. Fertility and … Web1 Jun 1992 · M. Laurikka-Routti, M. Haukkamaa, O. Heikinheimo. A contraceptive ring releasing ethinyl estradiol and the progestin ST-1435: bleeding control, serum steroid concentrations, serum lipids and serum chemistry. Contraception, 42 (1990), pp. 111-120. View PDF View article View in Scopus Google Scholar. 12. flags and what they mean https://fore-partners.com

Contraception with subdermal implants releasing the

WebMarjut Laurikka-Routti Naistentautien ja synnytysten erikoislääkäri Näytä vapaat ajat Hinnasto Esittely Hoidan laajalti gynekologisia vaivoja ja asioita: vaihdevuosia, ehkäisyä, … WebDOI: 10.1016/0010-7824(81)90115-3 Corpus ID: 72256207; Contraception with subcutaneous capsules containing ST-1435. Pituitary and ovarian function and plasma levels of ST-1435 Web8 Mar 2024 · Naistentautien ja synnytysten erikoislääkäri Marjut Laurikka-Routti sanoo, että kiusallisista vaihdevuosioireista ei kannata kärsiä, koska ne voidaan poistaa hormonihoidolla tehokkaasti. Aamutohtorin aiheena … canon exchange camera

Pharmacokinetics and bioavailability of ST 1435 administered by ...

Category:A contraceptive subdermal implant releasing the ... - ScienceDirect

Tags:Laurikka-routti

Laurikka-routti

A contraceptive subdermal implant releasing the …

WebThese implants have been developed for contraception and they have a life-time of two years. Three implant lengths of 4, 6 and 8 cm were tested to find the optimal steroid dose … Web680 Laurikka-Routti et a1. Transdermal ST 1435 and ovarian function Fertility and Sterility . testosterone (3) are routinely given transdermally. Until now, the choice of trans dermal progestins has been limited (4, 5). The synthetic progestin ST 1435, 19-norproges ...

Laurikka-routti

Did you know?

Web1 Nov 1992 · Laurikka-Routti M 1. Author information. Affiliations. 1 author. 1. City Maternity Hospital, Helsinki, Finland. Obstetrics and Gynecology, 01 Nov 1992, 80(5): 855-859 … WebM Laurikka-Routti To study the changes in serum lipids, serum chemistry, blood pressure, and body weight in long-term users of subcutaneous contraceptive implants releasing the …

WebLaurikka-Routti, M., & Haukkamaa, M. (1992). A contraceptive subdermal implant releasing the progestin ST-1435 - ovarian-function, bleeding patterns, and side-effects. Fertility and … Web1 Feb 2003 · Europe PMC is an archive of life sciences journal literature.

WebDOI: 10.1016/0010-7824(92)90140-O Corpus ID: 210060; Contraception with subdermal implants releasing the progestin ST-1435: a dose-finding study. … WebIn a fol-vaginal ring formulation (Laurikka-Routti, Haukkamaa, & low-up study to assess the long-term effects of the LNG-Heikinheimo, 1990) and transdermally (Haukkamaa, Lau- IUS system (Ronnerdag & Odlind, 1999), 100 patients rikka-Routti, & Heikinheimo, 1991). To determine whether ...

Web1 Oct 1992 · M. Laurikka-Routti, M. Haukkamaa, O. Heikinheimo A contraceptive vaginal ring releasing ethinyl estradiol and the progestin ST-1435: bleeding control, serum steroid concentrations, serum lipids and serum chemistry Contraception, 42 ( 1990), pp. 111 - 120 View PDF View article View in Scopus Google Scholar 10.

Web1 Jul 1990 · M. Laurikka-Routti, M. Haukkamaa, P. Lähteenmäki Medicine 1992 11 PDF A contraceptive subdermal implant releasing the progestin ST-1435: ovarian function, … flags and there nameWebLaurikka-Routti, Marjut ; Haukkamaa, Maija. / A contraceptive subdermal implant releasing the progestin ST-1435 - ovarian-function, bleeding patterns, and side-effects.Julkaisussa: Fertility and Sterility : official journal of the American Fertility Society . 1992 ; Vuosikerta 58.Sivut 1142-1147. can one work when on social securityWeb1 Jan 1992 · M Laurikka-Routti, M Haukkamaa, O Heikinheimo A contraceptive vaginal ring releasing ethinyl estradiol and the progestin ST-1435: Bleeding control, serum steroid … canon exchange programWeb1 Sep 1991 · Europe PMC is an archive of life sciences journal literature. canon extender rf2xWebThe progest in ST 1435, used parenterally for contraception or progestin therapy, had no adverse effects on serum lipids, blood pressure, or body weight, which are known to be risk factors for coronary artery disease. Objective: To study the changes in serum lipids, serum chemistry, blood pressure, and body weight in long-term users of subcutaneous … canon exchange roller kit for dr-m160Web1 Jan 1992 · Europe PMC is an archive of life sciences journal literature. canon ext. rf1.4xWeb1 Sep 1994 · M Laurikka-Routti Serum lipids, blood pressure, body weight and serum chemistry in women using subcutaneous contraceptive implants releasing the progestin … flags are us coupon